KALA BIO Balance Sheet Health
Financial Health criteria checks 5/6
KALA BIO has a total shareholder equity of $13.7M and total debt of $36.8M, which brings its debt-to-equity ratio to 268.3%. Its total assets and total liabilities are $61.6M and $47.9M respectively.
Key information
268.3%
Debt to equity ratio
US$36.80m
Debt
| Interest coverage ratio | n/a |
| Cash | US$54.20m |
| Equity | US$13.72m |
| Total liabilities | US$47.89m |
| Total assets | US$61.61m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0JQ2's short term assets ($58.9M) exceed its short term liabilities ($19.2M).
Long Term Liabilities: 0JQ2's short term assets ($58.9M) exceed its long term liabilities ($28.7M).
Debt to Equity History and Analysis
Debt Level: 0JQ2 has more cash than its total debt.
Reducing Debt: 0JQ2's debt to equity ratio has increased from 164.8% to 268.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0JQ2 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0JQ2 has sufficient cash runway for 1.5 years if free cash flow continues to grow at historical rates of 7.8% each year.